This breakthrough formula targets the pathways that trigger communication between the skin and the brain, interrupting the skin’s discomfort cycle by increasing beta-endorphins and suppressing the transient receptor potential vanilloid 1 (TRPV1) to reduce discomfort while helping support regenerating the epidermal barrier so compromised skin can recover faster.